Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Generic minoxidil receives FDA approval

April 16, 1997

Faulding launches wound care line in Australia and New Zealand

April 15, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

April 14, 1997

Connetics commences phase III trial for betamethasone mousse

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

ProCyte reports results from hair growth trial

April 7, 1997

Pharmadigm's PB-OO5 enters phase II as burn treatment

April 2, 1997

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...